Prasad Devarajan1. 1. Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, Ohio 45229-3039, USA. prasad.devarajan@cchmc.org
Abstract
PURPOSE OF REVIEW: Acute kidney injury (AKI) is a common and serious condition, the diagnosis of which depends on serum creatinine, which is a delayed and unreliable indicator of AKI. Fortunately, understanding the early stress response of the kidney to acute injuries has revealed a number of potential biomarkers. The current status of the most promising of these novel AKI biomarkers, including neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), liver-type fatty acid binding protein (L-FABP), and interleukin (IL)-18, is reviewed. RECENT FINDINGS: In particular, NGAL is emerging as an excellent biomarker in the urine and plasma, for the early prediction of AKI, for monitoring clinical trials in AKI, and for the prognosis of AKI in several common clinical scenarios. However, biomarker combinations may be required to improve our ability to predict AKI and its outcomes in a context-specific manner. SUMMARY: It is vital that additional large future studies demonstrate the association between biomarkers and hard clinical outcomes independent of serum creatinine concentrations and that randomization to a treatment for AKI based on high biomarker levels results in an improvement in clinical outcomes.
PURPOSE OF REVIEW: Acute kidney injury (AKI) is a common and serious condition, the diagnosis of which depends on serum creatinine, which is a delayed and unreliable indicator of AKI. Fortunately, understanding the early stress response of the kidney to acute injuries has revealed a number of potential biomarkers. The current status of the most promising of these novel AKI biomarkers, including neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), liver-type fatty acid binding protein (L-FABP), and interleukin (IL)-18, is reviewed. RECENT FINDINGS: In particular, NGAL is emerging as an excellent biomarker in the urine and plasma, for the early prediction of AKI, for monitoring clinical trials in AKI, and for the prognosis of AKI in several common clinical scenarios. However, biomarker combinations may be required to improve our ability to predict AKI and its outcomes in a context-specific manner. SUMMARY: It is vital that additional large future studies demonstrate the association between biomarkers and hard clinical outcomes independent of serum creatinine concentrations and that randomization to a treatment for AKI based on high biomarker levels results in an improvement in clinical outcomes.
Authors: Gebhard Wagener; Michael Jan; Mihwa Kim; Kiyoshi Mori; Jonathan M Barasch; Robert N Sladen; H Thomas Lee Journal: Anesthesiology Date: 2006-09 Impact factor: 7.892
Authors: C R Parikh; A Jani; J Mishra; Q Ma; C Kelly; J Barasch; C L Edelstein; P Devarajan Journal: Am J Transplant Date: 2006-07 Impact factor: 8.086
Authors: Orfeas Liangos; Mary C Perianayagam; Vishal S Vaidya; Won K Han; Ron Wald; Hocine Tighiouart; Robert W MacKinnon; Lijun Li; Vaidyanathapuram S Balakrishnan; Brian J G Pereira; Joseph V Bonventre; Bertrand L Jaber Journal: J Am Soc Nephrol Date: 2007-01-31 Impact factor: 10.121
Authors: C R Parikh; J Mishra; H Thiessen-Philbrook; B Dursun; Q Ma; C Kelly; C Dent; P Devarajan; C L Edelstein Journal: Kidney Int Date: 2006-05-17 Impact factor: 10.612
Authors: Mark M Mitsnefes; Thelma S Kathman; Jaya Mishra; Janis Kartal; Philip R Khoury; Thomas L Nickolas; Jonathan Barasch; Prasad Devarajan Journal: Pediatr Nephrol Date: 2006-10-27 Impact factor: 3.714
Authors: Oriana Ramírez-Rubio; Juan José Amador; James S Kaufman; Daniel E Weiner; Chirag R Parikh; Usman Khan; Michael D McClean; Rebecca L Laws; Damaris López-Pilarte; David J Friedman; Joseph Kupferman; Daniel R Brooks Journal: Nephrol Dial Transplant Date: 2015-08-25 Impact factor: 5.992
Authors: Rajeev Verma; Avijeet Chopra; Charles Giardina; Venkata Sabbisetti; Joan A Smyth; Lawrence E Hightower; George A Perdrizet Journal: Cell Stress Chaperones Date: 2015-02-04 Impact factor: 3.667